Archit Organosys Ltd (ARCHITORG) is currently trading at 62.50 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Archit Organosys Limited is engaged in manufacturing and trading of chemical products, primarily serving sectors like agrochemicals, pharmaceuticals, and cosmetics. The company has expanded its international reach, with sales spanning the USA, Europe, Latin America, Asia, and South Africa, indicating a strong global presence. Strategically located in Bhavnagar, Gujarat, their facility boosts capacity for products like Monochloroacetic Acid and Sodium Monochloro Acetate since 2017-18. Archit Organosys established a subsidiary, Shri Chlochem Global FZE, in UAE, and this international expansion supports their global sales efforts. In 2023, Archit incorporated Archit Life Science Limited, further diversifying its operations and enhancing its market presence through subsidiary expansion.

Over the past 52 weeks, Archit Organosys Ltd has traded between a low of ₹34.00 and a high of ₹71.99. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Archit Organosys Ltd has a market capitalization of approximately 122.47. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Archit Organosys Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 37.45 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 122.47 Cr, Archit Organosys Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Archit Organosys Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Archit Organosys Ltd is 37.45. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The board meeting is scheduled for August 12, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.

The board meeting is scheduled for September 3, 2026, as disclosed to the BSE.